Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville...

FDA Recall #D-0998-2020 — Class II — March 2, 2020

Recall #D-0998-2020 Date: March 2, 2020 Classification: Class II Status: Terminated

Product Description

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Reason for Recall

Product Mix-Up: A foreign tablet was found in bottle.

Recalling Firm

Mayne Pharma Inc — Greenville, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

8274 100-count bottles

Distribution

Distributed Nationwide in the USA

Code Information

Lot: FG11514 Exp. 05/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls